Tris Pharma Pays Texas $7.5 Million to Settle Claims It Overstated ADHD Drug Dyanavel XR While Denying Wrongdoing
Tris Pharma will pay Texas $7.5 million to settle claims that it overstated ADHD drug Dyanavel XR's benefits for kids. The company denies wrongdoing.
Medical Daily ·